A Study of Contribution of 3D Models in Resection of Renal Cell Cancer

Overview

About this study

The purpose of this study is to evaluate the impact on surgical planning and patient acceptance and understanding of 3D kidney tumor models prior to surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects are required to meet the following inclusion criteria:

  • Male and female subjects between 3 months and 88 years of age, inclusive.
  • Diagnosis of a renal tumor.
  • Renal tumor surgery is being considered.
  • Ability to provide written, informed consent prior to initiation of any study-related procedures, and ability, in the opinion of the principle investigator, to comply with all.

Exclusion Criteria:

Subjects will be excluded if they meet any of the following exclusion criteria prior to enrollment:

  • Clinically significant concomitant systemic disease that in the surgeon’s opinion the utilization of 3D models may not be appropriate.
  • Surgery is planned for a date that will not allow time enough for the 3D model to be made (usually 2 weeks).
  • The preoperative imaging study does not meet the basic minimum requirements necessary to the create an acceptable 3D model.
  • If the patient only has inadequate outside CT or MR images for use in creating 3D model.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Bradley Leibovich, M.D.

Closed for enrollment

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Akira Kawashima, M.D., Ph.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions